Rockefeller Capital Management L.P. Evolus, Inc. Transaction History

Rockefeller Capital Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$10.22 - $13.94 $10,220 - $13,940	-1,000 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$8.42 - $13.96 $4,210 - $6,980	500 Added 100.0%	1,000 $12,000
Q1 2021 May 11, 2021	BUY	$3.2 - $16.51 $1,312 - $6,769	410 Added 455.56%	500 $6,000
Q4 2020 Feb 12, 2021	SELL	$2.92 - $4.84 $3,007 - $4,985	-1,030 Reduced 91.96%	90 $0
Q3 2020 Nov 13, 2020	BUY	$3.03 - $5.48 $3,393 - $6,137	1,120 New	1,120 $4,000
Q2 2020 Aug 12, 2020	SELL	$3.53 - $6.17 $3,177 - $5,553	-900 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$3.53 - $12.21 $1,765 - $6,105	-500 Reduced 35.71%	900 $4,000
Q3 2019 Nov 12, 2019	BUY	$13.91 - $19.87 $19,474 - $27,818	1,400 New	1,400 $22,000

166

49.4M

453K

14K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $767M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.